Here’s How Authorities Could Generate a Monkeypox ‘Pandemic’ Using COVID-19 and Smallpox ‘Vaccine’ Reactions as Cover (Opinion)

Will the powers that be use cases of shingles and chickenpox (especially induced by the COVID-19 “vaccines”) as well as the side effects of smallpox vaccinations, as examples of “monkeypox” cases in a new “pandemic”? Here’s a look at how that could be done.

Many people online are speculating that governments around the globe may soon use shingles outbreaks due to the COVID-19 “vaccines”—which are undoubtedly causing recurrences of the infection from the varicella zoster virus (VZV)—to claim there is a new monkeypox “pandemic.” But while this prediction may not be exactly correct, it may be in the ballpark. Because chickenpox and monkeypox, apparently, look quite similar when it comes to clinical diagnosis. And chickenpox infection—which is also caused by VZV—is also an adverse event of the COVID-19 “vaccines.” As well as other types of “vaccines” on the normal U.S. vaccine schedule.

Making matters more confusing is the fact that the U.S. federal government—and presumably other governments across the globe—have already stocked up on polymerase chain reaction (PCR) tests for detecting whether or not somebody has the monkeypox virus. Unfortunately—or fortunately for anybody who would want to inflate “case” counts—the PCR tests health authorities could (and likely will) deploy are only specific enough to detect the Poxviridae family of viruses—which includes, along with the virus that causes monkeypox—smallpox (or variola) viruses, vaccinia virus, cowpox virus, and rabbitpox virus. (Other, less relevant viruses also belong to Poxviridae.)

If those in charge—namely the WHO, the World Economic Forum (WEF), intelligence agencies from various countries, etc.—wish to, they could easily generate a “pandemic” using faulty PCR testing, just as was done with COVID-19. (Note that even the CDC admits the PCR tests used for COVID-19 could not distinguish between the “novel” disease and various other influenza viruses and coronaviruses.) The PCR test is general enough to pick up on infections that are unavoidable thanks to “vaccines” like the one for smallpox. And clinical symptoms for the disease could (will?) come from “vaccinated” people who develop vaccinia infections and/or pox-like lesions.

It can also be assumed that in a setting of complete fear and panic people everywhere will mistake outbreaks of acne or severe rashes for monkeypox. After all, monkeypox, apparently, often takes on the appearance of such relatively minor skin irritations.

With this possibility—or, more likely, inevitability—in mind, below is an overview of how authorities could declare a monkeypox “pandemic” under the cover of other types of infections; including those that present as adverse events in response to normal “vaccinations,” including the ones for smallpox and COVID-19.


According to the Cleveland Clinic monkeypox “is a rare disease similar to smallpox caused by the monkeypox virus. It’s found mostly in areas of Africa, but has been seen in other areas of the world.” Cleveland Clinic notes the disease was discovered in 1958 when two outbreaks of “a pox-like disease” occurred in groups of monkeys being used for research. (A “pox” is a viral disease characterized by pustules or eruptions.)

Cleveland Clinic says that scientists aren’t certain, but they believe the disease is “spread by small rodents and squirrels in the rainforests of Africa.” Although the Centers for Disease Control and Prevention (CDC) says that “The first human case of monkeypox was recorded in 1970 in the Democratic Republic of Congo during a period of intensified effort to eliminate smallpox.” The CDC adds that, since then, “monkeypox has been reported in humans in other central and western African countries.”

Image: CDC

As the CDC notes, monkeypox virus belongs to the Orthopoxvirus genus of viruses, in the family Poxviridae. The Orthopoxvirus genus also includes variola virus (which causes smallpox), vaccinia virus—used in the smallpox vaccine—and cowpox virus.

As for the disease itself, the CDC says that (in humans) “the symptoms of monkeypox are similar to but milder than the symptoms of smallpox.” The agency notes a symptomatic monkeypox infection begins with fever, headache, muscle aches, and exhaustion. Monkeypox, unlike smallpox, also causes lymph nodes to swell (lymphadenopathy). Within 1 to 3 days—or sometimes longer—after the appearance of fever, an infected person will then develop a rash; one often beginning on the face and then spreading to other parts of the body.

Lesions that appear on the skin (above) also progress through the following stages before falling off: macules, papules, vesicles, pustules, and, finally, scabs. The CDC adds the illness typically lasts for 2−4 weeks, although it “has been shown to cause death in as many as 1 in 10 persons who contract the disease.”


Chickenpox, which is also known as varicella, is a highly contagious disease caused by an infection with the varicella zoster virus (VZV). The disease causes small, itchy blisters to form on the skin, which eventually scab over. The infection usually presents on the chest, back, and face, and then spreads to the rest of the body. The infection’s symptoms—including fever, tiredness, and headaches—last, on average, about five to seven days.

The CDC notes that “Chickenpox can be serious, especially in babies, adolescents, adults, pregnant women, and people with bodies that have a lowered ability to fight germs and sickness (weakened immune system).” The CDC also notes that “Chickenpox used to be very common in the United States” and that “In the early 1990s, an average of 4 million people got chickenpox, 10,500 to 13,000 were hospitalized, and 100 to 150 died each year.”

Images left to right: Gzzz / User:MarcoRoatan / ILJR

According to the Mayo Clinic shingles is a viral infection that causes a painful rash that can occur anywhere on one’s body, but most often occurring as a single stripe of blisters that wraps around either the left or the right side of the torso. As with the chickenpox virus, shingles is caused by VZV. Indeed, shingles is supposedly a reactivation of VZV some number of years after having had chickenpox. “[T]he virus lies inactive in nerve tissue near your spinal cord and brain,” the Mayo Clinic says, adding that “Years later, the virus may reactivate as shingles.”

The Clinic goes on to note that shingles isn’t a life-threatening condition, but can be very painful. There’s also early treatment that can help shorten a shingles infection and lessen the chance of complications from the disease. The most common complication, the Clinic notes, is postherpetic neuralgia, which causes shingles pain even after one’s blisters have cleared.

Image: Asvmdrn

Smallpox is an infectious disease caused by one of two virus variants; Variola major and Variola minor. The agent of variola virus (VARV) belongs to the genus Orthopoxvirus. The last naturally occurring case was diagnosed in October 1977, and the WHO certified the global eradication of the disease in 1980, making it the only human disease to be eradicated.

Note that the Mayo Clinic says, however, that samples of smallpox virus have been kept for research purposes. And “advances in synthetic biology have made it possible to create smallpox from published amino acid sequences.” This ability, the Mayo Clinic says, has “led to concerns that smallpox could someday be used as a biological warfare agent.”

Image: CDC

As for smallpox’s symptoms, it depends on the type with which somebody becomes infected. As the infection’s Wikipedia page notes, there is “ordinary” smallpox; “modified” smallpox; “malignant” smallpox; and, finally, “hemorrhagic” smallpox. Regardless of type, however, all variations normally include fever and vomiting, as well as a rash on the skin consisting of characteristic fluid-filled blisters with dents in their centers. Prior to its eradication, the disease was spread between people or via contaminated objects.

Each of the four types of smallpox infection is dastardly and horrific in its own right—with malignant smallpox having a near 100% death rate, and hemorrhagic smallpox having a high death rate as well, on top of gruesome symptoms like extensive bleeding underneath the skin. It is the “modified” version of smallpox that is most concerning in this context, however. Namely, because it’s easy to see how it could be clinically mistaken for monkeypox and can occur after smallpox vaccination.

Image: Wikipedia


Regardless of how unique or overlapping smallpox, shingles, chickenpox, and monkeypox are, what matters in this context—that is, in the context of defending ourselves against government tyranny by understanding its schemes—is how, and to what extent, the former three infections could be played off as the last one. To that end, it should first be noted that things don’t look good. In fact, it seems that the same COVID-19 “narrative” from 2020 will be re-applied this year, but with monkeypox as the disease du jour instead of the “novel coronavirus.”

The Washington Post, for example, has already noted that the government is well stocked with—you guessed it—polymerase chain reaction (PCR) test kits primed and ready to detect monkeypox. Apparently at least 74 state, federal, and local veterinary laboratories are all already ready to process the tests (should the need arise).

WaPo reports the network of testing facilities already has a capacity of up to 7,000 tests per week. Although, and here’s the kicker: “Technically, the CDC considers a positive PCR test from one of these labs a ‘preliminary’ diagnosis,” WaPo reports, “since the test identifies a family of viruses, not monkeypox itself… [and] confirmatory testing can only be performed at a CDC facility.”

This, of course, means the PCR tests health authorities will inevitably use to diagnose people initially as “presumptively positive” (which they can use as an excuse for lockdowns, quarantines, etc.) will commonly confuse monkeypox with other viruses in the family, Poxviridae, which include orthopoxvirus viruses; i.e. the smallpox viruses, vaccinia virus, cowpox virus, and rabbitpox virus along with the monkeypox virus.

This means, of course, that health departments across the country—indeed, across the world—will be able to deploy an overly broad PCR test that will catch other types of infections aside from monkeypox infections. And it’s unequivocal that recurrences of vaccinia virus infection—and smallpox lesions themselves—occur after smallpox “vaccination.” Here are several examples of such viral reactivations post vaccination in the Vaccine Adverse Event Reporting System (VAERS) reports:

From the VAERS reports it’s easy to see that anytime somebody is (supposedly) inoculated against smallpox, they run the risk of developing a vaccinia reaction; often with pox-like lesions on the skin. And keep in mind that, according to a study commissioned by the Department of Health and Human Services (HHS) in 2011, VAERS captures less than 1% of adverse events reported for any given “vaccine.”

In other words, the health departments are going to deploy a PCR test that picks up on vaccinia infections, and vaccinia infections are apparently common after smallpox vaccination.

Of course, this problem could made perhaps 100(?), 1,000(?) times worse if the media whips the public into a frenzy over the threat of monkeypox. Specifically because it seems the government is already angling itself to offer mass “monkeypox vaccination”—which is really smallpox vaccination, because the smallpox vaccine is literally used for monkeypox as well. (According to the FDA approval for the “vaccine,” it has, in fact, only been shown to protect animals against monkeypox.)

Paul Chaplin, President and CEO of vaccine producer Bavarian Nordic, announced in a May 18, 2022 press release that “the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has exercised the first options under the contract to supply a freeze-dried version of JYNNEOS® smallpox vaccine, thus allowing for the first doses of this version to be manufactured and invoiced in 2023 and 2024.” These options are valued at $119 million and represent the first ones exercised to convert bulk vaccine, which has already been manufactured and invoiced under previous contracts with BARDA, into freeze dried doses of JYNNEOS smallpox vaccine.

Link to FDA approval

Jynneos, according to the Food and Drug Administration (FDA), can also be used for monkeypox. The agency put out a press release on September 24, 2019 announcing “the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.” The FDA added: “This is the only currently FDA-approved vaccine for the prevention of monkeypox disease.”

Worse yet, it’s easy to see how just about any infection involving pox—or eruptions of the skin and mucous membranes—could be misconstrued for a monkeypox case. The WHO lists the symptoms of the disease—in the tweet above—as: “rash with blisters on face, hands, feet, body, eyes, mouth or genitals”; fever; swollen lymph nodes; headaches; muscle and back aches; and low energy.

It’s also easy to see how the monkeypox “cases” health departments identify with the overly broad PCR test could lead to an increased uptake in “monkeypox vaccines” (a.k.a. smallpox vaccines), increasing the number of vaccinia infections as adverse events. At this point, a feedback loop between “cases” and “vaccinations” would spool up.

Interestingly, lymph swelling—from moderate to severe—is a common side effect of the COVID-19 “vaccines.” As of this writing 16,312 VAERS reports contain the phrase “swollen lymph,” which, again, is likely only 1% (or less) of the real number of cases amongst the general “vaccinated” population.

On top of a too-general PCR test, the obvious prospect of clinical misdiagnosis—fed by an inevitable increased uptake in monkeypox (i.e. smallpox) “vaccines”—means it would (will) be exceptionally easy for the CDC, et al. to claim there is an ever-growing number of monkeypox “cases” in whichever country they’d like.

Indeed, the medical establishment is already performing the function of generalizing monkeypox—that is, widening its theoretical scope of transmission pathways and symptoms.

In a correspondence in The Lancet on June 15, 2022, for example, authors Daniel Pan, et al. wrote that “Transmission within the community is already taking place. To untrained eyes, monkeypox could easily be mistaken for other dermatological diagnoses within sexual health clinics or primary care (eg, chickenpox, varicella zoster, herpes simplex, syphilitic chancre, gonorrhea, or molluscum contagiosum).” The authors added that “We propose that probable case definitions of monkeypox be broadened to include anyone with an unexplained vesiculo-pustular rash on any part of their body with associated prodrome of fever, malaise, and lymphadenopathy so that fewer cases are missed in the community.”

Pan et al. also wrote that:

“Although assumptions of asymptomatic and airborne transmission of monkeypox might be premature, in the context of yet another outbreak rapidly spreading across the world, the possibility of such transmission modalities must be considered. We must take a precautionary infection control approach to control the spread of the virus while completing urgent research to understand better the human-to-human monkeypox transmission process.”

Clinical similarities between the way chickenpox and monkeypox present have also now been established in the medical literature. In a study published in the journal Acta Tropica, for example, authors Z. Jezek et al. wrote that:

“3.3% of human monkeypox cases were found among 730 patients diagnosed as cases of chickenpox, 7.3% among cases diagnosed as “atypical chickenpox” and 6.1% among cases with skin rash for which clinical diagnosis could not be established. The diagnostic difficulties were mainly based on clinical features characteristic of chickenpox: regional pleomorphism (in 46% of misdiagnosed cases), indefinite body-distribution of skin eruptions (49%), and centripetal distribution of skin lesions (17%). Lymph-node enlargement was observed in 76% of misdiagnosed patients. In the absence of smallpox, the main clinical diagnostic problem is the differentiation of human monkeypox from chickenpox. The presence of lymphadenopathy, pre-eruptive fever and slower maturation of skin lesions are the most important clinical signs supporting correct diagnosis of monkeypox.”

In a June 1, 2022 analysis by Dr. Michael Palmer of, the medical practitioner wrote:

“It has been suggested that the recent monkeypox might simply have been conjured up to
provide cover for the increased occurrence of shingles after COVID-19 vaccination…
which is likely due to these vaccines’ immunosuppressive effects… . However, it should
be easy enough to differentiate these two diseases. The skin lesions do look different, and
moreover shingles are typically confined to a single dermatome, that is, a skin area whose
sensory nerves originate from a single dorsal root of the spinal cord. A somewhat more plausible error is to confuse chickenpox and monkeypox. Chickenpox and shingles are caused by the same virus that (the Varicella-Zoster Virus, which belongs to the Herpes group), but chickenpox causes a generalized rash. Even though the aspect of the lesions is different—in particular, with monkeypox, all lesions develop synchronously, whereas with chickenpox multiple stages occur side by side—it seems that this error has indeed been common during monkeypox outbreaks in Africa… .”

Along with using an overly broad PCR test, the ease with which multiple, common pox infections can be mistaken for monkeypox, and the likely increase in monkeypox “vaccinations” from coming hysteria—and thusly pox-looking side effects—the media has already primed the population for a “second pandemic.”

President Joe Biden, for example, said on June 21, 2022 that there will be “a second pandemic.”

On June 15, 2022, Dr. Maria Van Kerkhove of the WHO said that “We are now seeing monkeypox circulating in countries that had never dealt with monkeypox before.”

Reports of supposedly confirmed monkeypox cases have been trickling into the U.S., as well as other Western countries, since early in 2021. On July 19, 2021, for example, Fox17 Nashville reported that “a Dallas resident has been confirmed as having a case of monkeypox.” The outlet reported that the resident had traveled from Nigeria back to Dallas, and that he’d been hospitalized. Fox17 was able to offer no images of the supposed monkeypox infection, however, and instead used stock images of the disease.

As of this writing the CDC is now tracking 173 “Total confirmed monkeypox/orthopoxvirus cases.” Incredibly, it seems the CDC is indeed not even attempting to separate out monkeypox infection from orthopoxvirus infections in general. The category “monkeypox/orthopoxvirus” is verbatim from the agency’s website.

The media has also teed up subtle panic cues for an incoming monkeypox pandemic. On November 18, 2021, for example, CNN reported that vials found at a vaccine research facility in Pennsylvania that were marked “smallpox” contained, in fact, “virus used to make the vaccine and not the virus that causes the disease… .” That is, vaccinia virus.

Earlier in the year, on January 24, 2022a truck hauling a trailer carrying 100 cynomolgus monkeys—the same type of monkey used for the studies supporting the efficacy of the Jynneos “vaccine,” as well as many other preclinical toxicology studies—was traveling to a “CDC-approved quarantine facility” in Florida when it took a left turn in front of a dump truck causing a collision. The incident took place near the community of Danville in Pennsylvania, and resulted in the accidental release of three monkeys. AP News, who reported on the incident, made no mention of the possibility of monkeypox.


At this point it’s abundantly clear that—between the non-specific PCR test, the clinical overlap between smallpox, monkeypox, and chickenpox, and the relatively generic symptoms laid out by the WHO—it would be easy for those in power to fake a monkeypox “pandemic.” Indeed, with the CDC declaring the existence of 173 “monkeypox/orthopoxvirus” cases in the United States already, we’ve already leap-frogged the 47 cases of monkeypox from the 2003 “outbreak” of the disease in the country.

If those in charge—namely the WHO, the World Economic Forum (WEF), intelligence agencies from various countries, etc.—wish to, they can clearly generate a “pandemic” using faulty PCR testing, just as was done with COVID-19. (Note that even the CDC admits the PCR tests used for COVID-19 could not distinguish between the “novel” disease and various other influenza viruses and coronaviruses.) Clinical symptoms for the disease will come from “vaccinated” people who develop vaccinia infections and/or develop pox-like lesions.

It can also be assumed that in a setting of complete fear and panic, people everywhere will mistake outbreaks of acne or severe rashes for monkeypox. After all, the disease, apparently, often takes on the appearance of such relatively minor ailments.

Is it a guarantee that authorities will attempt to generate and then use a monkeypox “pandemic” to further implement a biomedical security state? Of course not. But it does seem exceptionally likely. Not only has the media been drumming up attention (and fear) for the disease, but in March of 2021 the Nuclear Threat Initiative—a nonprofit organization founded in 2001 by former U.S. Senator Sam Nunn and media entrepreneur Ted Turner—partnered with the Munich Security Conference to conduct a tabletop exercise on “reducing high-consequence biological threats,” focusing on monkeypox. In the video immediately below, chair of the NTI-bio Advisory Group Peggy Hamburg recaps the exercise with colleagues.

Billionaire and former BlackRock fund manager Edward Dowd, who has been right about a lot concerning world politics since 2020, also said in an interview with Alex Jones in June of this year that he believes those in power will lock down the Western world again due to a hyped threat of a monkeypox pandemic. The fund manager believes there will specifically be lockdowns in the U.S. in 2022 in order to subvert the midterm elections.

As of this writing the WHO has convened to discuss if the (supposed) ongoing outbreaks of monkeypox across the globe warrant the declaration of a Public Health Emergency of International Concern (or PHEIC; literally pronounced “fake”).

Feature image: Зонов Евгений Владимирович

(Visited 3 times, 1 visits today)

Accessibility Toolbar